Concepedia

LI Chang-feng

LC

7

Publications

483

Citations

7

H-Index

2012

Active since

Affiliations

Jilin University(Current)

Union Hospital

Union Hospital

LI Chang-feng is an author at Jilin University specializing in tumor biology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2012–2020

7

Publications

7

LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.

Dayong Ding, LI Chang-feng, Tiancheng Zhao et al. · PubMed · 2018 · 181 citations · Full text

A novel circFMN2 promotes tumor proliferation in CRC by regulating the miR-1182/hTERT signaling pathways

Yongchao Li, LI Chang-feng, Ruisi Xu et al. · Clinical Science · 2019 · 88 citations · Full text

Procaine is a specific DNA methylation inhibitor with anti‐tumor effect for human gastric cancer

Y Y Li, Yun Wang, Dandan Li et al. · Journal of Cellular Biochemistry · 2017 · 68 citations

, , +27

The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer

Ruisi Xu, Xiaodong Wu, Siqi Zhang et al. · International Journal of Oncology · 2012 · 61 citations · Full text

, , +12

The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma

LI Chang-feng, Yongchao Li, Yun Wang et al. · Cellular Physiology and Biochemistry · 2018 · 55 citations · Full text

Rows per page

1–5 of 7